TRT Myths Debunked: 10 Things
People Get Wrong

Testosterone replacement therapy is one of the most misunderstood treatments in medicine. Despite decades of clinical use and a growing body of rigorous research, myths and misconceptions persist — fueled by conflation with anabolic steroid abuse, outdated medical assumptions, and sensationalized media coverage. These myths don't just cause confusion — they prevent men who genuinely need treatment from seeking it.

Here are 10 of the most common TRT myths, what the evidence actually says, and why the distinction matters.

Myth #1: "TRT Causes Heart Attacks"

This is perhaps the most damaging myth about TRT, and it persists despite definitive evidence to the contrary. The fear originated from two flawed studies published in 2010 and 2013 — both of which had significant methodological problems. The TOM trial studied frail elderly men with mobility limitations, a population very different from typical TRT candidates. The Vigen et al. JAMA study contained statistical errors that led over 160 physicians to demand retraction.

The definitive answer came from the TRAVERSE trial, published in the New England Journal of Medicine in 2023. This was the largest randomized controlled trial ever conducted on testosterone and cardiovascular safety — 5,246 men with low testosterone who also had pre-existing cardiovascular disease or high cardiac risk, followed for an average of 33 months. The result: testosterone therapy did not increase heart attacks, strokes, or cardiovascular death. Even in the highest-risk patients, there was no increase in major adverse cardiovascular events. For a complete review of the cardiovascular evidence, read our article on TRT and heart health.

Myth #2: "TRT Causes Prostate Cancer"

This myth has its roots in 1940s research by Charles Huggins, who observed that castration slowed advanced prostate cancer — and won a Nobel Prize for the discovery. The assumption was logical but wrong: if removing testosterone slows prostate cancer, adding testosterone must fuel it. This belief dominated urology for over half a century and caused generations of men with low T to be denied treatment.

Modern research has thoroughly debunked this. The saturation model, proposed by Abraham Morgentaler at Harvard Medical School, demonstrates that prostate tissue has a limited number of androgen receptors that become fully saturated at relatively low testosterone levels — around 250 ng/dL. Once saturated, additional testosterone does not stimulate further prostate growth. Multiple large studies, including meta-analyses and the TRAVERSE trial's prostate safety data, have confirmed that TRT does not increase the risk of prostate cancer. Some researchers have even explored testosterone therapy in men with treated prostate cancer, with results suggesting no increased risk of recurrence.

That said, prostate monitoring remains important — not because TRT causes cancer, but because prostate cancer is common in men, and regular screening (PSA and clinical exam) is good medicine regardless of TRT status.

Myth #3: "TRT Is Just Steroids"

This conflation causes enormous harm. Anabolic steroid abuse involves taking testosterone and other androgens at doses 5 to 20 times higher than what the body naturally produces — often cycling multiple compounds, using unregulated products, and doing so without medical supervision or blood work. The health consequences of steroid abuse are real and well-documented: liver damage, cardiac hypertrophy, HDL suppression, psychological changes, and fertility impairment.

TRT is fundamentally different. It involves replacing testosterone to physiological (normal) levels in men who have documented deficiency — confirmed by blood tests. The doses used in TRT are designed to bring testosterone to the mid-normal range, not to supraphysiological levels. It's supervised by a physician with regular blood work monitoring. Comparing TRT to steroid abuse is like comparing insulin therapy for diabetes to recreational drug use — the substance might be similar, but the dose, purpose, and context are entirely different.

Myth #4: "TRT Causes 'Roid Rage'"

The "roid rage" phenomenon is associated with supraphysiological doses of androgens — not with physiological replacement. Studies on testosterone replacement therapy consistently show that restoring normal testosterone levels improves mood, reduces irritability, and decreases anxiety. A 2019 meta-analysis in JAMA Psychiatry found that TRT actually reduced depressive symptoms and improved emotional well-being.

Here's the irony: low testosterone is far more likely to cause irritability and mood instability than normal testosterone levels. Men with hypogonadism frequently report being short-tempered, easily frustrated, and emotionally volatile. TRT typically improves these symptoms — making men more even-keeled, not more aggressive. If a patient on TRT does experience increased irritability, it usually indicates a dosing issue (testosterone too high) or elevated estradiol from aromatization — both of which are easily corrected with proper monitoring.

Myth #5: "TRT Will Make You Infertile"

This one is partially true but needs important context. Exogenous testosterone suppresses the HPG axis, which reduces or eliminates sperm production in most men. This effect is dose-dependent and typically reversible upon stopping TRT, though recovery can take 3 to 12 months. For men who are actively trying to conceive or want to preserve fertility, this is a genuine consideration.

However, calling TRT "a male contraceptive" is inaccurate. Not all men experience complete suppression — some maintain residual sperm production on TRT, making it unreliable as a contraceptive method. More importantly, there are strategies to maintain fertility while treating low testosterone. Medications like hCG (human chorionic gonadotropin) can be prescribed alongside TRT to maintain testicular function and sperm production. Clomiphene citrate is another option that raises testosterone by stimulating the body's own production pathway rather than replacing it externally.

At Revive, we discuss fertility plans with every patient before starting therapy. For men who want to maintain fertility, we design protocols that address both testosterone deficiency and reproductive function. The myth that TRT means permanent infertility is simply wrong — but the fertility conversation needs to happen before treatment starts, not after.

Myth #6: "You'll Be Dependent on TRT Forever"

The word "dependent" implies addiction, which is misleading. TRT is not addictive — it doesn't produce euphoria, tolerance, or compulsive drug-seeking behavior. What is true is that if you have clinically low testosterone due to an underlying cause (primary or secondary hypogonadism), that condition doesn't go away. Stopping TRT means returning to your previous low testosterone state and the symptoms that came with it.

This is the same as any other hormone replacement — a person with hypothyroidism takes thyroid medication indefinitely because their thyroid doesn't produce enough hormone on its own. A person with type 1 diabetes takes insulin for the same reason. TRT works the same way. If your body doesn't produce adequate testosterone, replacement therapy addresses the deficiency. Calling this "dependency" would be like calling thyroid medication an addiction.

That said, some men's low testosterone has reversible causes — obesity, sleep apnea, medications, chronic stress. In these cases, addressing the underlying cause may restore natural testosterone production, potentially allowing discontinuation of TRT. Your physician should always investigate reversible causes as part of the initial evaluation.

Myth #7: "Natural Methods Can Replace TRT"

Lifestyle optimization — exercise, sleep, nutrition, stress management, weight loss — is important and should be part of every man's health strategy. These factors can genuinely support healthy testosterone production and may raise levels modestly. But for men with clinically low testosterone confirmed by blood work, lifestyle changes alone are rarely sufficient to restore normal levels.

Here's the math: the most optimistic studies on exercise-induced testosterone increases show improvements of 15 to 20 percent. If your total testosterone is 200 ng/dL, a 20% improvement brings you to 240 ng/dL — still well below the clinical threshold. For men with primary hypogonadism (where the testes simply don't produce enough testosterone), no amount of exercise, supplements, or sleep optimization will overcome the underlying physiological limitation.

As for "testosterone boosting supplements" — the vast majority have no meaningful clinical evidence behind them. A comprehensive review published in the World Journal of Men's Health found that most over-the-counter testosterone supplements had no effect on serum testosterone levels, and some actually contained substances that could suppress testosterone production. The supplement industry is largely unregulated, and the claims made on product labels don't require clinical proof. Read more in our article on natural ways to boost testosterone.

Myth #8: "TRT Is Only for Older Men"

While testosterone decline accelerates with age, low testosterone is not exclusively an age-related condition. Men in their 20s, 30s, and 40s can have clinically low testosterone due to a variety of causes: pituitary dysfunction, Klinefelter syndrome, testicular injury, medications (particularly opioids), obesity, and other medical conditions. Studies show that approximately 20 percent of men aged 15 to 39 have testosterone levels below 300 ng/dL.

For younger men, the diagnostic approach may be different — there's a greater emphasis on identifying reversible causes and considering fertility implications — but the need for treatment is just as real. A 35-year-old with a testosterone level of 180 ng/dL is just as symptomatic and just as deserving of treatment as a 55-year-old with the same level.

Myth #9: "All TRT Clinics Are the Same"

The TRT landscape has expanded dramatically, but the quality of care varies enormously. Some clinics run 4-marker lab panels and prescribe one-size-fits-all protocols with minimal follow-up. Telehealth companies may evaluate you in a 10-minute video call and ship compounded testosterone without comprehensive blood work. Others operate more like optimization clinics, pushing doses to the upper extreme and treating testosterone levels as a score to maximize rather than a health marker to optimize.

A quality TRT clinic should run comprehensive lab work (at least 30+ markers, ideally 50+), see you in person for physical examination, recheck labs at 6 weeks after starting treatment, prescribe FDA-approved testosterone to a local pharmacy where your insurance can cover it, and maintain ongoing monitoring with the same physician. If a clinic doesn't offer these basics, you're not getting the standard of care you deserve. For a detailed comparison, read our guide to TRT clinic vs. telehealth vs. your PCP.

Myth #10: "If My Testosterone Is 'Normal,' I Don't Need Treatment"

This might be the most insidious myth because it's used by well-meaning physicians to dismiss real suffering. Lab reference ranges for testosterone are incredibly broad — most labs define "normal" as 264 to 916 ng/dL. That's a range of over 650 ng/dL, which means a man with a level of 280 ng/dL and a man with a level of 900 ng/dL are both classified as "normal" despite having vastly different hormonal status.

Reference ranges represent the statistical distribution of test results in a population — they're not clinical thresholds. They include samples from obese men, sleep-deprived men, and men with chronic illness. Being at the bottom of this range while experiencing clear symptoms of low testosterone is clinically significant, even if the lab report says "normal." Experienced hormone physicians treat the patient, not just the number — considering symptoms, free testosterone, SHBG, and the overall clinical picture alongside total testosterone.